Literature DB >> 6883712

Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid.

R Dauberschmidt, P J Marangos, J Zinsmeyer, V Bender, G Klages, J Gross.   

Abstract

In nine patients with severe head trauma, the concentration of neuron-specific enolase in cerebrospinal fluid and in plasma was determined and compared with the activity of creatine kinase and alpha-hydroxybutyrate dehydrogenase, and with the concentration of lactate. In patients who died of the head trauma, a concentration of neuron-specific enolase of 6.8-64 micrograms/l in the plasma (reference range: 3.0-6.0 micrograms/l) and of 2.2-9.0 micrograms/l in the cerebrospinal fluid (reference range: 0.5-2.0 micrograms/l) was detected. Investigations of three patients showed that the changes of the concentration of neuron-specific enolase in plasma and in cerebrospinal fluid were independent of each other. Furthermore, the initial concentration of neuron-specific enolase in the plasma after the accident and the dynamics of its changes during the disease show a close relationship to the outcome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883712     DOI: 10.1016/0009-8981(83)90085-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

Review 2.  Blood biomarkers for brain injury: What are we measuring?

Authors:  Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford
Journal:  Neurosci Biobehav Rev       Date:  2016-05-12       Impact factor: 8.989

3.  Ventricular tapping seems to have no influence on S-100B and NSE serum concentrations.

Authors:  Chris Woertgen; Ruth Albert; Markus Köhler; Angela Rzepecki; Ralf Dirk Rothoerl; Thomas Bein; Alexander Brawanski
Journal:  Neurosurg Rev       Date:  2004-05-01       Impact factor: 3.042

4.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

Review 5.  Brain dysfunction in critically ill patients--the intensive care unit and beyond.

Authors:  Nuala J Meyer; Jesse B Hall
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 6.  Bench-to-bedside review: critical illness-associated cognitive dysfunction--mechanisms, markers, and emerging therapeutics.

Authors:  Eric B Milbrandt; Derek C Angus
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 7.  The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.

Authors:  Feng Cheng; Qiang Yuan; Jian Yang; Wenming Wang; Hua Liu
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

Review 8.  Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.

Authors:  Eric Peter Thelin; Frederick Adam Zeiler; Ari Ercole; Stefania Mondello; András Büki; Bo-Michael Bellander; Adel Helmy; David K Menon; David W Nelson
Journal:  Front Neurol       Date:  2017-07-03       Impact factor: 4.003

9.  The cloning and characterization of the enolase2 gene of Gekko japonicus and its polyclonal antibody preparation.

Authors:  Jing Li; Ronghua Wu; Haijiao Chen; Youlang Zhou; Yan Li; Yongjun Wang; Yan Liu; Mei Liu
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

10.  Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.

Authors:  Eric Peter Thelin; Emma Jeppsson; Arvid Frostell; Mikael Svensson; Stefania Mondello; Bo-Michael Bellander; David W Nelson
Journal:  Crit Care       Date:  2016-09-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.